#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia refractory Aspergillus infection Still's disease Richter's syndrome Hepatic cirrhosis Proteus syndrome Uveal melanoma Waldenstrom's macroglobulinaemia Biliary neoplasm Skin cancer Cutaneous T-cell lymphoma stage II Kawasaki's disease Arteriosclerosis Metabolic disorder Ichthyosis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Life with Disease Angiosarcoma non-metastatic – Basic Information Systemic mastocytosis – Treatment Pituitary-dependent Cushing’s syndrome – Trials in Disease Mantle cell lymphoma stage III – Treatment Marginal zone lymphoma refractory – Diagnostics Short-bowel syndrome – Diagnostics Rosai-Dorfman syndrome – Treatment Prader-Willi syndrome – Trials in Disease Bronchiolitis obliterans syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pariglasgene Brecaparvovec Alizapride Cefuroxime Sodium Methylprednisolone Acetate Tegafur Benralizumab Cevostamab Pralsetinib Amniotic Membrane, Human KETOROLAC Azd5492 Fenoterol Hydrobromide Immunoglobulin M Citalopram Hydrobromide ISPAGHULA HUSK Rmc-035 Df6002 Abbv-668 Lactose Melatonin More therapies…

    Learn about Your Condition

    Monogenic diabetes Bone marrow failure Stem cell transplant Connective tissue disorder Fibrosarcoma Lyme disease Atrophic vulvovaginitis Apathy Renal cancer Periarthritis Hyperinsulinism Post-traumatic stress disorder Mitral valve prolapse Schizophrenia Pyelonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Effect of bupropion hydrochloride and mushroom supplement on body weight in overweight adults: a 52‑week randomized trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic syndrome
    • Overweight
    Investigated Drugs:
    • Bupropion Hydrochloride
    Sweden

  • Phase 3 study of mitapivat for effectiveness and safety in children with non‑transfusion‑dependent alpha or beta thalassemia

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Mitapivat
    Greece Italy

  • Privosegtor Added to Standard IV Methylprednisolone in Patients with Optic Neuritis: Randomized Placebo‑Controlled Trial

    Not yet recruiting

    3 1
    France Germany Italy Spain

  • Surgery versus Lauromacrogol 400 injection for superficial labial venous malformations in children and adults: a randomized controlled trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malformation venous
    Investigated Drugs:
    • Lauromacrogol 400
    France

  • Fosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amikacin Sulfate
    • Aztreonam
    • Cefepime
    France

  • A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Sapablursen
    Austria Czechia France Germany Hungary Italy +3
Previous Page
1 … 658 659 660 661 662 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!